Journal
LEUKEMIA
Volume 36, Issue 11, Pages 2647-2655Publisher
SPRINGERNATURE
DOI: 10.1038/s41375-022-01700-3
Keywords
-
Categories
Funding
- German Cancer Consortium joint funding program (DKTK CHOICE)
- Deutsche Forschungsgemeinschaft [SFB 1243, SPP-2084]
- German Jose Carreras Leukamie-Stiftung [DJCLS R14/18, DJCLS 03R/2018]
- Wilhelm Sander Stiftung [WSS/TUD/2018.123.1]
- European Research Council under the European Union [953407]
- Marie Curie Actions (MSCA) [953407] Funding Source: Marie Curie Actions (MSCA)
Ask authors/readers for more resources
This study investigated CH driver mutations in healthy individuals and found that variant allele frequencies were higher in BM compared to PB, positively correlated with the number of driver variants, and remained stable during follow-up. Spatial heterogeneity was detected in CH carriers, with different ASXL1 mutations showing distinct lineage distribution patterns. Patients with myeloid malignancies had higher mutation numbers and allele frequencies.
Clonal hematopoiesis (CH) is characterized by somatic mutations in blood cells of individuals without hematologic disease. While the mutational landscape of CH in peripheral blood (PB) has been well characterized, detailed analyses addressing its spatial and cellular distribution in the bone marrow (BM) compartment are sparse. We studied CH driver mutations in healthy individuals (n = 261) across different anatomical and cellular compartments. Variant allele frequencies were higher in BM than PB and positively correlated with the number of driver variants, yet remained stable during a median of 12 months of follow-up. In CH carriers undergoing simultaneous bilateral hip replacement, we detected ASXL1-mutant clones in one anatomical location but not the contralateral side, indicating intra-patient spatial heterogeneity. Analyses of lineage involvement in ASXL1-mutated CH showed enriched clonality in BM stem and myeloid progenitor cells, while lymphocytes were particularly involved in individuals carrying the c.1934dupG variant, indicating different ASXL1 mutations may have distinct lineage distribution patterns. Patients with overt myeloid malignancies showed higher mutation numbers and allele frequencies and a shifting mutation landscape, notably characterized by increasing prevalence of DNMT3A codon R882 variants. Collectively, our data provide novel insights into the genetics, evolution, and spatial and lineage-specific BM involvement of CH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available